{"id":"W2070825440","doi":"10.1016/s1470-2045(15)70122-1","title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":1255,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Cancer Foundation","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Ipilimumab; Placebo; Medicine; Adjuvant; Oncology; Melanoma; Internal medicine; Stage (stratigraphy); Resection; Surgery; Cancer; Immunotherapy; Cancer research; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001993023,0.002541378,0.004826581,0.0005933294,0.0005385854,0.001435873,0.001238397,0.002437604,0.008890889],"category_scores_gemma":[0.001585758,0.00105985,0.002722472,0.0005308776,0.001715611,0.001453315,0.000577355,0.004327897,0.001838615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009609409,"about_ca_system_score_gemma":0.001191981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001441163,"about_ca_topic_score_gemma":0.002300788,"domain_scores_codex":[0.9992923,0.0003288153,0.00003508508,0.0001450975,0.00004017409,0.0001585386],"domain_scores_gemma":[0.9991688,0.0002602693,0.0001813948,0.00006882993,0.00003944203,0.0002813556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9904242,0.002206098,0.00007775342,0.0003385847,0.0003237345,0.00001146355,0.00002033339,0.0001511293,0.0009082681,0.00004972273,0.0003700703,0.005118601],"study_design_scores_gemma":[0.9674887,0.03134043,0.0003531947,0.00002011014,0.0002004056,0.000009773281,0.000009053897,0.0001693009,0.0001197114,0.00008295406,0.0001968338,0.000009428751],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771506,0.008274632,0.001433822,0.001128884,0.001756356,0.005426227,0.001385291,0.0003260288,0.003118211],"genre_scores_gemma":[0.9768289,0.004378559,0.001763385,0.001475357,0.000984208,0.006050042,0.001085358,0.00006190748,0.007372298],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008890889,"threshold_uncertainty_score":0.02974302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1165948738888528,"score_gpt":0.3704590522131933,"score_spread":0.2538641783243404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}